Cosmo Pharmaceuticals N.V. (LON: 0RGI)

Market Cap	938.90M
Revenue (ttm)	157.15M
Net Income (ttm)	58.99M
Shares Out	n/a
EPS (ttm)	3.66
PE Ratio	15.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9
Average Volume	479
Open	65.70
Previous Close	65.50
Day's Range	65.70 - 65.80
52-Week Range	33.75 - 68.60
Beta	1.29
RSI	60.37
Earnings Date	Mar 6, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1997
• Employees: 325
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RGI

Financial Performance

Financial numbers in EUR